StepStone Group LP — 13F Holdings & Portfolio

CIK 1502287 · latest 13F-HR filed 2026-05-15

StepStone Group LP manages $207.5M in 13F-reported U.S. long-equity assets across 18 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are KRMN (33.85%), STUB (22.74%), XNDU (12.62%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 3 new positions, exited 8, added to 5, and trimmed 9.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM

$207.5M

Long-equity book

Holdings

18

Distinct positions

Period

2026-03-31

Filed 2026-05-15

Q/Q Activity

+3 / −8 / ↑5 / ↓9

vs 2025-12-31

Firm Profile & Key People
Name Title / Status Ownership Type

Top Adds (vs prior quarter)

  • KARMAN HLDGS INC$57.8M +465.0%
  • ONKURE THERAPEUTICS INC$9.7M +714.2%
  • ENTRADA THERAPEUTICS INC.$1.8M +22.8%
  • CHIME FINL INC$945.0K +50.7%
  • GROVE COLLABORATIVE HOLD INC$68.5K +16.4%
Show all 5

Top Trims

  • STUBHUB HLDGS INC-$55.1M -53.9%
  • KODIAK AI INC.-$5.6M -36.5%
  • UIPATH, INC.-$4.8M -32.3%
  • GEN DIGITAL INC-$2.6M -91.2%
  • SERVICENOW INC-$2.3M -97.2%
Show all 9

New Positions

  • XANADU QUANTUM TECHNOLO LTD$26.2M
  • EIKON THERAPEUTICS INC$4.2M
  • MONGODB INC.$496.9K
Show all 3

Exited Positions

  • FIGMA INC$3.4M
  • RUBRIK INC$1.4M
  • CIRCLE INTERNET GROUP INC$741.6K
  • PDD HOLDINGS INC$561.9K
  • REVOLUTION MEDICINES INC$475.6K
Show all 8
All Holdings

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 KARMAN HLDGS INC KRMN 485924104 $70.2M 33.85% 877,320 SH
2 STUBHUB HLDGS INC STUB 86384P109 $47.2M 22.74% 7,562,225 SH
3 XANADU QUANTUM TECHNOLO LTD XNDU 98390R102 $26.2M 12.62% 3,417,854 SH
4 ONKURE THERAPEUTICS INC OKUR 68277Q105 $11.0M 5.31% 2,660,612 SH
5 UIPATH, INC. PATH 90364P105 $10.0M 4.83% 902,973 SH
6 KODIAK AI INC. KDK 500081104 $9.8M 4.73% 1,412,702 SH
7 ENTRADA THERAPEUTICS INC. TRDA 29384C108 $9.6M 4.63% 761,277 SH
8 NAVAN INC NAVN 639193101 $6.4M 3.09% 483,901 SH
9 PHATHOM PHARMACEUTICALS INC. PHAT 71722W107 $4.7M 2.26% 422,085 SH
10 EIKON THERAPEUTICS INC EIKN 282564103 $4.2M 2.02% 395,340 SH
11 DRAFTKINGS INC NEW DKNG 26142V105 $3.5M 1.68% 160,902 SH
12 CHIME FINL INC CHYM 16935C109 $2.8M 1.35% 150,000 SH
13 MONGODB INC. MDB 60937P106 $496.9K 0.24% 2,030 SH
14 GROVE COLLABORATIVE HOLD INC GROV 39957D201 $487.3K 0.23% 380,702 SH
15 TENAYA THERAPEUTICS INC TNYA 87990A106 $318.9K 0.15% 462,163 SH
16 GEN DIGITAL INC GENVR 668771116 $249.2K 0.12% 622,931 SH
17 VIA TRANSN INC VIA 92556W104 $240.0K 0.12% 16,002 SH
18 SERVICENOW INC NOW 81762P102 $66.7K 0.03% 638 SH
Filing History
Period Filed AUM Holdings Accession
2026-03-31 2026-05-15 $207.5M 18 0001193125-26-225924
2025-12-31 2026-02-17 $186.9M 23 0001193125-26-053625
2025-09-30 2025-11-14 $212.7M 16 0001193125-25-281926